Universal Cells
Rosa Suen has extensive experience in research and laboratory operations. Rosa has held positions such as Manager, Lab Operations at Universal Cells, Senior Research Associate at Seattle Biomedical Research Institute, Research Associate IV at Institute for Systems Biology, and Senior Associate Scientist at ACT-1 on assignment at Amgen Inc. Rosa's work has involved studying T cell signaling, microbiome effects on T cell function, superinfection biology, Dicer and microRNA regulation of innate immunity. With a Bachelor of Science degree in Biochemistry from The University of Hong Kong, Rosa Suen's career showcases their expertise in experimental research and laboratory management.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.